Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-2071-2025

CHANGE HEALTHCARE CANADA COMPANY recalls Change Healthcare Cardiology Hemo Software

CHANGE HEALTHCARE CANADA COMPANYRichmond, CanadaReported Jul 9, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

Due to complaints, software update may cause software to unexpectedly shutdown.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Change Healthcare Cardiology Hemo Software

Lot / code information

UDI
(01)17540262100051/ 15.0.1/
UDI
(01)17540262100105

What the firm is doing

On May 22, 2025, Change Healthcare issued a "Urgent Field Safety notice" to affected consignees via e-mail. On May June 11, 2025, Change Healthcare sent out an updated notification providing additional information. Change Healthcare asked consignees to take the following actions: 1. Change Healthcare has developed a software update that addresses this issue. Contact Change Healthcare support to schedule its deployment. 2. This notice must be distributed to all personnel within your organization who need to be aware of this notice. Customers should alert other affiliated parties that may be affected by this notice. 3. please maintain awareness of this Urgent Field Safety Notice until the issue has been fully resolved. 4. Please notify our Customer Support department that you have read and understood this field safety notice.

DistributionShow details

Worldwide - US Nationwide distribution in the states of AL, AR, CA, FL, KY MO, MS, NE, NH, NJ, PA, TN, TX, WA and the countries of Australia, Canada, Germany, Great Britain, Ireland, Israel, New Zealand.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls